CPA
Cowen Prime Advisors Portfolio holdings
AUM
$290M
This Quarter Return
-15.6%
1 Year Return
+57.79%
3 Year Return
+115.61%
5 Year Return
+253.96%
10 Year Return
+968.93%
AUM
$238M
AUM Growth
+$238M
(-19%)
Cap. Flow
-$4.47M
Cap. Flow
% of AUM
-1.88%
Top 10 Holdings %
Top 10 Hldgs %
57.75%
Holding
183
New
9
Increased
29
Reduced
30
Closed
5
Top Buys
| 1 |
RDNW
RideNow Group, Inc. Class B Common Stock
RDNW
|
$4.24M |
| 2 |
Thryv Holdings
THRY
|
$2.85M |
| 3 |
Intel
INTC
|
$2.14M |
| 4 |
NeoGenomics
NEO
|
$1.91M |
| 5 |
Aspen Aerogels
ASPN
|
$1.84M |
Top Sells
| 1 |
VG
Vonage Holdings Corporation
VG
|
$11.3M |
| 2 |
Nephros
NEPH
|
$2.43M |
| 3 |
PDF Solutions
PDFS
|
$1.3M |
| 4 |
Leidos
LDOS
|
$1.27M |
| 5 |
GAN
GAN Ltd
GAN
|
$901K |
Sector Composition
| 1 | Technology | 38.56% |
| 2 | Industrials | 14.28% |
| 3 | Communication Services | 12.37% |
| 4 | Healthcare | 11.84% |
| 5 | Consumer Discretionary | 9.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Accuray
ARAY
$157M
| $550K | 0.23% | 166,286 -4,800 | -3% | -$15.9K |
|
52
Research Solutions
RSSS
$98.3M
| $537K | 0.23% | 252,000 -251,000 | -50% | -$535K |
|
53
Corteva
CTVA
$50.4B
| $524K | 0.22% | 9,116 -100 | -1% | -$5.75K |
|
54
Blackstone
BX
$134B
| $520K | 0.22% | 4,100 | – | – |
|
55
Kopin
KOPN
$342M
| $507K | 0.21% | 200,200 -6,700 | -3% | -$17K |
|
56
Nutanix
NTNX
$18B
| $462K | 0.19% | 17,230 -300 | -2% | -$8.04K |
|
|
HTGM
57
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
| $462K | 0.19% | 332,197 -260,936 | -44% | -$363K |
|
58
Golub Capital BDC
GBDC
$3.97B
| $446K | 0.19% | 29,324 +1,624 | +6% | +$24.7K |
|
59
Lantheus
LNTH
$3.73B
| $445K | 0.19% | 8,050 -2,150 | -21% | -$119K |
|
60
Ares Capital
ARCC
$15.8B
| $419K | 0.18% | 20,000 | – | – |
|
61
Ribbon Communications
RBBN
$722M
| $415K | 0.17% | 134,219 -7,000 | -5% | -$21.6K |
|
|
VG
62
DELISTED
Vonage Holdings Corporation
VG
| $386K | 0.16% | 19,000 -555,900 | -97% | -$11.3M |
|
63
Constellation Energy
CEG
$96.2B
| $385K | 0.16% | +6,841 | New | +$385K |
|
64
Novo Nordisk
NVO
$251B
| $361K | 0.15% | 3,250 | – | – |
|
|
65
Nephros
NEPH
$39.5M
| $354K | 0.15% | 80,400 -552,650 | -87% | -$2.43M |
|
66
QuidelOrtho
QDEL
$1.95B
| $337K | 0.14% | +3,000 | New | +$337K |
|
67
MetLife
MET
$54.1B
| $327K | 0.14% | 4,650 | – | – |
|
|
RADA
68
DELISTED
Rada Electronic Industries Ltd
RADA
| $320K | 0.13% | 23,000 | – | – |
|
69
Kinder Morgan
KMI
$60B
| $306K | 0.13% | 16,180 | – | – |
|
70
Allot
ALLT
$362M
| $297K | 0.13% | 36,649 +9,874 | +37% | +$80K |
|
71
Teva Pharmaceuticals
TEVA
$21.1B
| $289K | 0.12% | 30,740 -300 | -1% | -$2.82K |
|
72
Trane Technologies
TT
$92.5B
| $283K | 0.12% | 1,850 | – | – |
|
73
National Research Corp
NRC
$339M
| $278K | 0.12% | 7,000 | – | – |
|
74
Exxon Mobil
XOM
$487B
| $278K | 0.12% | 3,370 | – | – |
|
75
Healthpeak Properties
DOC
$12.5B
| $275K | 0.12% | 8,000 | – | – |
|